Rheumatoid Arthritis Therapeutics

Rheumatoid Arthritis Therapeutics

Rheumatoid Arthritis Therapeutics market worldwide is projected to grow by US$7.6 Billion, driven by a compounded growth of 4.4%. Pharmaceuticals, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$12.2 Billion by the year 2025, Pharmaceuticals will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$269.7 Million to the region's size and clout in the next 5 to 6 years. Over US$222 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pharmaceuticals will reach a market size of US$617.8 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.9% over the next couple of years and add approximately US$2.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, AbbVie, Inc.; Amgen, Inc.; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis International AG; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; UCB SA

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Rheumatoid Arthritis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Rheumatoid Arthritis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Rheumatoid Arthritis Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Rheumatoid Arthritis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Pharmaceuticals (Type) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Pharmaceuticals (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Pharmaceuticals (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Biopharmaceuticals (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Biopharmaceuticals (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Biopharmaceuticals (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Prescription (Sales Channel) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: Prescription (Sales Channel) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: Prescription (Sales Channel) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Over-the-Counter (OTC) (Sales Channel) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Over-the-Counter (OTC) (Sales Channel) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Over-the-Counter (OTC) (Sales Channel) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Rheumatoid Arthritis Therapeutics Market Share (in %) by Company: 2019 & 2025
TABLE 16: United States Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 17: Rheumatoid Arthritis Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
TABLE 18: United States Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 19: United States Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Sales Channel: 2018 to 2025
TABLE 20: Rheumatoid Arthritis Therapeutics Market in the United States by Sales Channel: A Historic Review in US$ Million for 2009-2017
TABLE 21: United States Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
CANADA
TABLE 22: Canadian Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 23: Canadian Rheumatoid Arthritis Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
TABLE 24: Rheumatoid Arthritis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 25: Canadian Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018 to 2025
TABLE 26: Canadian Rheumatoid Arthritis Therapeutics Historic Market Review by Sales Channel in US$ Million: 2009-2017
TABLE 27: Rheumatoid Arthritis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Sales Channel for 2009, 2019, and 2025
JAPAN
TABLE 28: Japanese Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 29: Rheumatoid Arthritis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 30: Japanese Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 31: Japanese Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Sales Channel for the Period 2018-2025
TABLE 32: Rheumatoid Arthritis Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Sales Channel for the Period 2009-2017
TABLE 33: Japanese Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
CHINA
TABLE 34: Chinese Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 35: Rheumatoid Arthritis Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017
TABLE 36: Chinese Rheumatoid Arthritis Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 37: Chinese Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Sales Channel for the Period 2018-2025
TABLE 38: Rheumatoid Arthritis Therapeutics Historic Market Analysis in China in US$ Million by Sales Channel: 2009-2017
TABLE 39: Chinese Rheumatoid Arthritis Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Rheumatoid Arthritis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 40: European Rheumatoid Arthritis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 41: Rheumatoid Arthritis Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 42: European Rheumatoid Arthritis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 43: European Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 44: Rheumatoid Arthritis Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 45: European Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 46: European Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018-2025
TABLE 47: Rheumatoid Arthritis Therapeutics Market in Europe in US$ Million by Sales Channel: A Historic Review for the Period 2009-2017
TABLE 48: European Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
FRANCE
TABLE 49: Rheumatoid Arthritis Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 50: French Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 51: French Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 52: Rheumatoid Arthritis Therapeutics Market in France by Sales Channel: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 53: French Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Sales Channel: 2009-2017
TABLE 54: French Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
GERMANY
TABLE 55: Rheumatoid Arthritis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 56: German Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 57: German Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 58: Rheumatoid Arthritis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 59: German Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 60: German Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
ITALY
TABLE 61: Italian Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 62: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
TABLE 63: Italian Rheumatoid Arthritis Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 64: Italian Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Sales Channel for the Period 2018-2025
TABLE 65: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Italy in US$ Million by Sales Channel: 2009-2017
TABLE 66: Italian Rheumatoid Arthritis Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
TABLE 67: United Kingdom Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 68: Rheumatoid Arthritis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 69: United Kingdom Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 70: United Kingdom Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Sales Channel for the Period 2018-2025
TABLE 71: Rheumatoid Arthritis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Sales Channel for the Period 2009-2017
TABLE 72: United Kingdom Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
SPAIN
TABLE 73: Spanish Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 74: Spanish Rheumatoid Arthritis Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
TABLE 75: Rheumatoid Arthritis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 76: Spanish Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018 to 2025
TABLE 77: Spanish Rheumatoid Arthritis Therapeutics Historic Market Review by Sales Channel in US$ Million: 2009-2017
TABLE 78: Rheumatoid Arthritis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Sales Channel for 2009, 2019, and 2025
RUSSIA
TABLE 79: Russian Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 80: Rheumatoid Arthritis Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
TABLE 81: Russian Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 82: Russian Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Sales Channel: 2018 to 2025
TABLE 83: Rheumatoid Arthritis Therapeutics Market in Russia by Sales Channel: A Historic Review in US$ Million for 2009-2017
TABLE 84: Russian Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 85: Rest of Europe Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 86: Rheumatoid Arthritis Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 87: Rest of Europe Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 88: Rest of Europe Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018-2025
TABLE 89: Rheumatoid Arthritis Therapeutics Market in Rest of Europe in US$ Million by Sales Channel: A Historic Review for the Period 2009-2017
TABLE 90: Rest of Europe Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 91: Asia-Pacific Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 92: Rheumatoid Arthritis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
TABLE 93: Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 94: Rheumatoid Arthritis Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 95: Asia-Pacific Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 96: Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 97: Rheumatoid Arthritis Therapeutics Market in Asia-Pacific by Sales Channel: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 98: Asia-Pacific Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Sales Channel: 2009-2017
TABLE 99: Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 100: Rheumatoid Arthritis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 101: Australian Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 102: Australian Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 103: Rheumatoid Arthritis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 104: Australian Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 105: Australian Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
INDIA
TABLE 106: Indian Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 107: Indian Rheumatoid Arthritis Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
TABLE 108: Rheumatoid Arthritis Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 109: Indian Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018 to 2025
TABLE 110: Indian Rheumatoid Arthritis Therapeutics Historic Market Review by Sales Channel in US$ Million: 2009-2017
TABLE 111: Rheumatoid Arthritis Therapeutics Market in India: Percentage Share Breakdown of Sales by Sales Channel for 2009, 2019, and 2025
SOUTH KOREA
TABLE 112: Rheumatoid Arthritis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 113: South Korean Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 114: Rheumatoid Arthritis Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
TABLE 115: Rheumatoid Arthritis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 116: South Korean Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 117: Rheumatoid Arthritis Therapeutics Market Share Distribution in South Korea by Sales Channel: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 118: Rest of Asia-Pacific Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 119: Rheumatoid Arthritis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 120: Rest of Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 121: Rest of Asia-Pacific Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Sales Channel for the Period 2018-2025
TABLE 122: Rheumatoid Arthritis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Sales Channel for the Period 2009-2017
TABLE 123: Rest of Asia-Pacific Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 124: Latin American Rheumatoid Arthritis Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
TABLE 125: Rheumatoid Arthritis Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 126: Latin American Rheumatoid Arthritis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 127: Latin American Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 128: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
TABLE 129: Latin American Rheumatoid Arthritis Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 130: Latin American Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Sales Channel for the Period 2018-2025
TABLE 131: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Latin America in US$ Million by Sales Channel: 2009-2017
TABLE 132: Latin American Rheumatoid Arthritis Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
TABLE 133: Argentinean Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 134: Rheumatoid Arthritis Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 135: Argentinean Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 136: Argentinean Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018-2025
TABLE 137: Rheumatoid Arthritis Therapeutics Market in Argentina in US$ Million by Sales Channel: A Historic Review for the Period 2009-2017
TABLE 138: Argentinean Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
BRAZIL
TABLE 139: Rheumatoid Arthritis Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 140: Brazilian Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 141: Brazilian Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 142: Rheumatoid Arthritis Therapeutics Market in Brazil by Sales Channel: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 143: Brazilian Rheumatoid Arthritis Therapeutics Historic Market Scenario in US$ Million by Sales Channel: 2009-2017
TABLE 144: Brazilian Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
MEXICO
TABLE 145: Rheumatoid Arthritis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 146: Mexican Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 147: Mexican Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 148: Rheumatoid Arthritis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 149: Mexican Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 150: Mexican Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 151: Rest of Latin America Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 152: Rheumatoid Arthritis Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
TABLE 153: Rest of Latin America Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 154: Rest of Latin America Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Sales Channel: 2018 to 2025
TABLE 155: Rheumatoid Arthritis Therapeutics Market in Rest of Latin America by Sales Channel: A Historic Review in US$ Million for 2009-2017
TABLE 156: Rest of Latin America Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 157: The Middle East Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 158: Rheumatoid Arthritis Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
TABLE 159: The Middle East Rheumatoid Arthritis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 160: The Middle East Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 161: The Middle East Rheumatoid Arthritis Therapeutics Historic Market by Type in US$ Million: 2009-2017
TABLE 162: Rheumatoid Arthritis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 163: The Middle East Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018 to 2025
TABLE 164: The Middle East Rheumatoid Arthritis Therapeutics Historic Market by Sales Channel in US$ Million: 2009-2017
TABLE 165: Rheumatoid Arthritis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Sales Channel for 2009, 2019, and 2025
IRAN
TABLE 166: Iranian Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 167: Rheumatoid Arthritis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 168: Iranian Rheumatoid Arthritis Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 169: Iranian Market for Rheumatoid Arthritis Therapeutics: Annual Sales Estimates and Projections in US$ Million by Sales Channel for the Period 2018-2025
TABLE 170: Rheumatoid Arthritis Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Sales Channel for the Period 2009-2017
TABLE 171: Iranian Rheumatoid Arthritis Therapeutics Market Share Analysis by Sales Channel: 2009 VS 2019 VS 2025
ISRAEL
TABLE 172: Israeli Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 173: Rheumatoid Arthritis Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 174: Israeli Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 175: Israeli Rheumatoid Arthritis Therapeutics Market Estimates and Forecasts in US$ Million by Sales Channel: 2018-2025
TABLE 176: Rheumatoid Arthritis Therapeutics Market in Israel in US$ Million by Sales Channel: A Historic Review for the Period 2009-2017
TABLE 177: Israeli Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 178: Saudi Arabian Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 179: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
TABLE 180: Saudi Arabian Rheumatoid Arthritis Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 181: Saudi Arabian Rheumatoid Arthritis Therapeutics Market Growth Prospects in US$ Million by Sales Channel for the Period 2018-2025
TABLE 182: Rheumatoid Arthritis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Sales Channel: 2009-2017
TABLE 183: Saudi Arabian Rheumatoid Arthritis Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
TABLE 184: Rheumatoid Arthritis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 185: United Arab Emirates Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 186: Rheumatoid Arthritis Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
TABLE 187: Rheumatoid Arthritis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 188: United Arab Emirates Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 189: Rheumatoid Arthritis Therapeutics Market Share Distribution in United Arab Emirates by Sales Channel: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 190: Rheumatoid Arthritis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 191: Rest of Middle East Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 192: Rest of Middle East Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 193: Rheumatoid Arthritis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Sales Channel for the Period 2018-2025
TABLE 194: Rest of Middle East Rheumatoid Arthritis Therapeutics Historic Market Analysis in US$ Million by Sales Channel: 2009-2017
TABLE 195: Rest of Middle East Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
AFRICA
TABLE 196: African Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 197: Rheumatoid Arthritis Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
TABLE 198: African Rheumatoid Arthritis Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 199: African Rheumatoid Arthritis Therapeutics Market Estimates and Projections in US$ Million by Sales Channel: 2018 to 2025
TABLE 200: Rheumatoid Arthritis Therapeutics Market in Africa by Sales Channel: A Historic Review in US$ Million for 2009-2017
TABLE 201: African Rheumatoid Arthritis Therapeutics Market Share Breakdown by Sales Channel: 2009 VS 2019 VS 2025
IV. COMPETITION
ABBVIE, INC.
AMGEN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB COMPANY
F. HOFFMANN-LA ROCHE AG
JOHNSON & JOHNSON
NOVARTIS INTERNATIONAL AG
PFIZER, INC
REGENERON PHARMACEUTICALS, INC.
UCB SA
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook